HPV vaccination in women aged 27 to 45 years: What do general practitioners think?

BMC Women's Health

Volumn 14, Issue 1, 2014, Pages

  Mazza, Danielle ^a   Petrovic, Katja ^a   Grech, Cathy ^a   Harris, Naomi ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Attitudes; Barriers; Beliefs; General practice; Human papillomavirus; Vaccination

Indexed keywords

WART VIRUS VACCINE;

ADULT; AGED; ARTICLE; AUSTRALIA; AWARENESS; BEHAVIOR CHANGE; CLINICAL ARTICLE; CONCEPTUAL FRAMEWORK; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG INFORMATION; FEMALE; GENERAL PRACTITIONER; GROUPS BY AGE; HEALTH BELIEF; HOSPITAL; HUMAN; MALE; NURSE; PAPILLOMAVIRUS INFECTION; SEMI STRUCTURED INTERVIEW; TELEPHONE INTERVIEW; UNCERTAINTY; UTERINE CERVIX CANCER; VACCINATION; ATTITUDE TO HEALTH; CLINICAL PRACTICE; DRUG COST; HEALTH PERSONNEL ATTITUDE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PATIENT ATTITUDE; TIME; UTERINE CERVICAL NEOPLASMS;

ADULT; ATTITUDE OF HEALTH PERSONNEL; AUSTRALIA; DRUG COSTS; FEMALE; GENERAL PRACTITIONERS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; PHYSICIAN'S PRACTICE PATTERNS; TIME FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 84904846181     PISSN: None     EISSN: 14726874     Source Type: Journal    
DOI: 10.1186/1472-6874-14-91     Document Type: Article

References (37)

1. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189(1):12-19. 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F, 10451482.
2. Schiller JT, Castellsague X, Garland SM. A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine 2012, 30(Suppl 5):F123-F138.
3. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, Vallejos CS, de Ruiz PA, Lima MA, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, Tatti SA, Kasamatsu E, Iljazovic E, Odida M, Prado R, Seoud M, Grce M, Usubutun A, Jain A, Suarez GA, Lombardi LE, Banjo A, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 2010, 11(11):1048-1056. 10.1016/S1470-2045(10)70230-8, 20952254.
4. National Health and Medical Research Council The Australian Immunisation Handbook 2013, Canberra: Department of Health and Ageing, Australian Government, 10, National Health and Medical Research Council.
5. Garland SM, Brotherton JM, Skinner SR, Pitts M, Saville M, Mola G, Jones RW. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention. Vaccine 2008, 26(S12):M80-M88.
6. National Health and Medical Research Council The Australian Immunisation Handbook 2009, Canberra: Australian Government Publishing Service, 9, National Health and Medical Research Council.
7. Wilkinson E. Australia leads way on HPV vaccination in boys. Lancet Infect Dis 2012, 12(11):831-832. 10.1016/S1473-3099(12)70282-7, 23256210.
8. Brotherton JM, Deeks SL, Campbell-Lloyd S, Misrachi A, Passaris I, Peterson K, Pitcher H, Scully M, Watson M, Webby R. Interim estimates of human papillomavirus vaccination coverage in the school-based program in Australia. Commun Dis Intell 2008, 32(4):457-461.
9. Weisberg E, Bateson D, McCaffery K, Skinner SR. HPV vaccination catch up program - utilisation by young Australian women. Aust Fam Physician 2009, 38(1):72-76.
10. Muñoz N, Manalastas R, Pitisuttithum P, Tresukosol D, Monsonego J, Ault K, Clavel C, Luna J, Myers E, Hood S, Bautista O, Bryan J. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial. Lancet 2009, 373:1949-1957. 10.1016/S0140-6736(09)60691-7, 19493565.
11. Brotherton JM, Mullins RM. Estimating coverage of the National HPV Vaccination Program: where are we at?. Med J Aust 2009, 191(3):188.
12. De Sanjose S, Diaz M, Castellsague´ X, Clifford G, Bruni L, Muñoz N, Bosch FX. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007, 7:453-459. 10.1016/S1473-3099(07)70158-5, 17597569.
13. Castellsague X, Munoz N, Pitisuttithum P, Ferris D, Monsonego J, Ault K, Luna J, Myers E, Mallary S, Bautista OM, Bryan J, Vuocolo S, Haupt RM, Saah A. End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age. Br J Cancer 2011, 105(1):28-37. 10.1038/bjc.2011.185, 3137403, 21629249.
14. Schwarz TF, Spaczynski M, Schneider A, Wysocki J, Galaj A, Perona P, Poncelet S, Zahaf T, Hardt K, Descamps D, Dubin G. Immunogenicity and tolerability of an HPV-16/18 AS04-adjuvanted prophylactic cervical cancer vaccine in women aged 15-55 years. Vaccine 2009, 27(4):581-587. 10.1016/j.vaccine.2008.10.088, 19022320.
15. Brotherton JM, Leask J, Jackson C, McCaffery K, Trevena LJ. National survey of general practitioners' experience of delivering the National Human Papillomavirus Vaccination Program. Sex Health 2010, 7:291-298. 10.1071/SH09135, 20719217.
16. Leask J, Jackson C, Trevena L, McCaffery K, Brotherton J. Implementation of the Australian HPV vaccination program for adult women: qualitative key informant interviews. Vaccine 2009, 27:5505-5512.
17. Sussman AL, Helitzer D, Sanders M, Urquieta B, Salvador M, Ndiaye K. HPV and cervical cancer prevention counseling with younger adolescents: Implications for primary care. Ann Fam Med 2007, 5(4):298-304. 10.1370/afm.723, 1934965, 17664495.
18. Brown ECF, Little P, Leydon GM. Communication challenges of HPV vaccination. Fam Pract 2010, 27(2):224-229. 10.1093/fampra/cmp087, 20022908.
19. Duval B, Gilca V, McNeil S, Dobson S, Money D, Gemmill IM, Sauvageau C, Lavoie F, Ouakki M. Vaccination against human papillomavirus: a baseline survey of Canadian clinicians' knowledge, attitudes and beliefs. Vaccine 2007, 25:7841-7847.
20. Esposito S, Bosis S, Pelucchi C, Begliatti E, Rognoni A, Bellasio M, Tel F, Consolo S, Principi N. Pediatrician knowledge and attitudes regarding human papillomavirus disease and its prevention. Vaccine 2007, 25:6437-6446.
21. Michie S, Johnston M, Abraham C, Lawton R, Parker D, Walker A, . Psychological Theory G Making psychological theory useful for implementing evidence based practice: a consensus approach. Qual Saf Health Care 2005, 14(1):26-33. 10.1136/qshc.2004.011155, 1743963, 15692000, Psychological Theory G.
22. Alexander KE, Brijnath B, Mazza D. Barriers and enablers to delivery of the Healthy Kids Check: an analysis informed by the Theoretical Domains Framework and COM-B model. Implement Sci 2014, 9:60. 4047437, 24886520.
23. Duncan EM, Cuthbertson BH, Prior ME, Marshall AP, Wells EC, Todd LE, Bolsover D, Newlands RS, Webster F, Rose L, Campbell MK, Bellingan G, Seppelt IM, Francis JJ, . SuDDICU International Study Group The views of health care professionals about selective decontamination of the digestive tract: An international, theoretically informed interview study. J Crit Care 2014, 29(4):634-640. SuDDICU International Study Group.
24. Penn L, Dombrowski SU, Sniehotta FF, White M. Perspectives of UK Pakistani women on their behaviour change to prevent type 2 diabetes: qualitative study using the theory domain framework. BMJ Open 2014, 4(7):e004530. 10.1136/bmjopen-2013-004530, 4091164, 25005595.
25. Tavender EJ, Bosch M, Gruen RL, Green SE, Knott J, Francis JJ, Michie S, O'Connor DA. Understanding practice: the factors that influence management of mild traumatic brain injury in the emergency department-a qualitative study using the Theoretical Domains Framework. Implement Sci 2014, 9:8. 3895840, 24418161.
26. Gerend MA, Shepherd MA, Shepherd JE. The multidimensional nature of perceived barriers: global versus practical barriers to HPV vaccination. Health Psychol 2013, 32(4):361-369. 3360988, 22059622.
27. Kahn JA, Rosenthal SL, Tissot AM, Bernstein DI, Wetzel C, Zimet GD. Factors influencing pediatricians' intention to recommend human papillomavirus vaccines. Ambul Pediatr 2007, 7(5):367-373. 10.1016/j.ambp.2007.05.010, 17870645.
28. Department of Health and Ageing Building a 21st Century Primary Health Care System: A Draft of Australia's First National Primary Health Care Strategy. Commonwealth of Australia 2009, Department of Health and Ageing.
29. Friedman AL, Shepeard H. Exploring the knowledge, attitudes, beliefs, and communication preferences of the general public regarding HPV: Findings from CDC focus group research and implications for practice. Health Educ Behav 2007, 34(3):471-485.
30. Shand L, Burney S, Fletcher J. Knowledge of cervical cancer, pap testing and the human papillomavirus among young Australian women. Health Promot J Aust 2010, 21:202-207.
31. Skinner SR, Kang M, Rosenthal SL. Vaccinating young adults against human papillomavirus: the importance of understanding health decision-making and behaviour. Sex Health 2007, 4:129-132. 10.1071/SH07005, 17524291.
32. Leval A, Herweijer E, Ploner A, Eloranta S, Fridman Simard J, Dillner J, Young C, Netterlid E, Sparen P, Arnheim-Dahlstrom L. Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study. J Natl Cancer Inst 2013, 105(7):469-474. 10.1093/jnci/djt032, 3614506, 23486550.
33. Chan SSC, Cheung TH, Lo WK, Chung TKH. Women's attitudes on human papillomavirus vaccination to their daughters. J Adolesc Health 2007, 41(2):204-207. 10.1016/j.jadohealth.2007.04.011, 17659226.
34. Kahn JA, Rosenthal SL, Jin Y, Huang B, Namakydoust A, Zimet GD. Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women. Obstet Gynecol 2008, 111(5):1103-1110. 10.1097/AOG.0b013e31817051fa, 18448742.
35. Conroy K, Rosenthal SL, Zimet GD, Jin Y, Bernstein DI, Glynn S, Kahn JA. Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. J Womens Health (Larchmt) 2009, 18(10):1679-1686. 10.1089/jwh.2008.1329, 19785564.
36. Hopkins TG, Wood N. Female human papillomavirus (HPV) vaccination: global uptake and the impact of attitudes. Vaccine 2013, 31(13):1673-1679. 10.1016/j.vaccine.2013.01.028, 23375978.
37. Sauvageau C, Duval B, Gilca V, Lavoie F, Ouakki M. Human papilloma virus vaccine and cervical cancer screening acceptability among adults in Quebec, Canada. BMC Public Health 2007, 7:304. 10.1186/1471-2458-7-304, 2206027, 17961209.